DrugCite
Search

ZELITREX

Adverse Events
Drug Profile
Learn More
Reference
About Results
Comments

Zelitrex Adverse Events Reported to the FDA Over Time

How are Zelitrex adverse event reports trending over time?

This graph shows volume of adverse events submitted to the FDA by quarter for Zelitrex, as well as related generic and/or brandname drugs containing the same primary active ingredients. Adverse events are counted if Zelitrex is flagged as the suspect drug causing the adverse event.

Most Common Zelitrex Adverse Events Reported to the FDA

What are the most common Zelitrex adverse events reported to the FDA?

Confusional State
43 (2.24%)
Renal Failure Acute
40 (2.08%)
Pyrexia
35 (1.82%)
Pruritus
26 (1.35%)
Toxic Skin Eruption
25 (1.3%)
Thrombocytopenia
24 (1.25%)
Overdose
23 (1.2%)
Cytolytic Hepatitis
22 (1.14%)
Dermatitis Exfoliative
19 (.99%)
Diarrhoea
19 (.99%)
General Physical Health Deteriorati...
19 (.99%)
Show More Show More
Hallucination
19 (.99%)
Leukopenia
19 (.99%)
Blood Creatinine Increased
18 (.94%)
Rash
18 (.94%)
Coma
17 (.88%)
Disorientation
17 (.88%)
Dizziness
17 (.88%)
Rash Erythematous
17 (.88%)
Anaemia
16 (.83%)
Oedema Peripheral
16 (.83%)
Rash Maculo-papular
16 (.83%)
Somnolence
16 (.83%)
Vomiting
16 (.83%)
Skin Exfoliation
15 (.78%)
Agranulocytosis
14 (.73%)
Gamma-glutamyltransferase Increased
14 (.73%)
Encephalopathy
13 (.68%)
Photosensitivity Reaction
13 (.68%)
Rash Papular
13 (.68%)
Asthenia
12 (.62%)
Eosinophilia
12 (.62%)
Erythema
12 (.62%)
Pain In Extremity
12 (.62%)
Abdominal Pain
11 (.57%)
Alanine Aminotransferase Increased
11 (.57%)
Blood Alkaline Phosphatase Increase...
11 (.57%)
Blood Lactate Dehydrogenase Increas...
11 (.57%)
Hypotension
11 (.57%)
Nausea
11 (.57%)
Neutropenia
11 (.57%)
Pancytopenia
11 (.57%)
Aspartate Aminotransferase Increase...
10 (.52%)
Drug Exposure During Pregnancy
10 (.52%)
Fall
10 (.52%)
Hallucination, Visual
10 (.52%)
Prurigo
10 (.52%)
Stevens-johnson Syndrome
10 (.52%)
Abdominal Pain Upper
9 (.47%)
C-reactive Protein Increased
9 (.47%)
Chills
9 (.47%)
Dehydration
9 (.47%)
Myoclonus
9 (.47%)
Tumour Lysis Syndrome
9 (.47%)
Vascular Purpura
9 (.47%)
Agitation
8 (.42%)
Hyperhidrosis
8 (.42%)
Jaundice
8 (.42%)
Loss Of Consciousness
8 (.42%)
Rhabdomyolysis
8 (.42%)
Cataract
7 (.36%)
Cholestasis
7 (.36%)
Drug Interaction
7 (.36%)
Drug Rash With Eosinophilia And Sys...
7 (.36%)
Dyspnoea
7 (.36%)
Fatigue
7 (.36%)
Headache
7 (.36%)
Hyperkalaemia
7 (.36%)
Hypothermia
7 (.36%)
Off Label Use
7 (.36%)
Sepsis
7 (.36%)
Altered State Of Consciousness
6 (.31%)
Anaemia Macrocytic
6 (.31%)
Aplasia Pure Red Cell
6 (.31%)
Balance Disorder
6 (.31%)
Blood Bilirubin Increased
6 (.31%)
Blood Urea Increased
6 (.31%)
Condition Aggravated
6 (.31%)
Depressed Level Of Consciousness
6 (.31%)
Disturbance In Attention
6 (.31%)
Drug Administration Error
6 (.31%)
Face Oedema
6 (.31%)
Hepatitis Cholestatic
6 (.31%)
Inflammation
6 (.31%)
Nervous System Disorder
6 (.31%)
Pain
6 (.31%)
Psoriasis
6 (.31%)
Renal Failure
6 (.31%)
Blood Creatine Phosphokinase Increa...
5 (.26%)
Bone Marrow Failure
5 (.26%)
Bradypnoea
5 (.26%)
Delirium
5 (.26%)
Drug Ineffective
5 (.26%)
Dysarthria
5 (.26%)
Gait Disturbance
5 (.26%)
Haemoglobin Decreased
5 (.26%)
Hepatitis
5 (.26%)
Lung Disorder
5 (.26%)
Mydriasis
5 (.26%)
Purpura
5 (.26%)
Renal Failure Chronic
5 (.26%)

ExportShare/Embed GraphExport Export Data

This graph shows the top adverse events submitted to the FDA for Zelitrex, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zelitrex is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Adverse Event Categories for Zelitrex

What are the most common Zelitrex adverse events reported to the FDA?

Show More Show More

ExportShare/Embed Graph Export Export Data

This graph shows the top categories of adverse events submitted to the FDA for Zelitrex, as well as related generic and/or brandname drugs containing the same primary active ingredients, from Q1 2004 to Q3 2012. Adverse events are counted if Zelitrex is flagged as a suspect drug causing the adverse event. For each adverse event listed, percent (%) represents percentage of the adverse event to all adverse events reported for the drug. Percent does not represent a rate related to drug utilization.

Common Uses of Zelitrex According to Those Reporting Adverse Events

Why are people taking Zelitrex, according to those reporting adverse events to the FDA?

Drug Use For Unknown Indication
140
Prophylaxis
94
Herpes Zoster
75
Product Used For Unknown Indication
64
Antiviral Prophylaxis
51
Herpes Virus Infection
49
Show More Show More
Infection Prophylaxis
30
Herpes Simplex
18
Oral Herpes
12
Herpes Ophthalmic
9
Genital Herpes
6
Pain Prophylaxis
5
Herpes Zoster Ophthalmic
5
Varicella
4
Ill-defined Disorder
4
Opportunistic Infection Prophylaxis
4
Fungal Infection
3
Chemotherapy
3
Tooth Disorder
2
Hyperthermia
2
Antibiotic Prophylaxis
2
Unevaluable Event
2
Acute Lymphocytic Leukaemia
2
Erythema Multiforme
2
Keratitis Herpetic
2
Mucosal Inflammation
2
Lung Infection
1
Prophylactic Chemotherapy
1
Eye Disorder
1
Rash
1
Scrotal Disorder
1
Hiv Infection
1
Drug Exposure During Pregnancy
1
Intentional Overdose
1
Genital Infection Female
1
Hodgkins Disease
1
Hepatitis Viral
1
Infection
1
Musculoskeletal Pain
1
Neuralgia
1
Bone Marrow Transplant
1
Herpes Simplex Serology Positive
1
Leukaemia
1
Encephalitis Herpes
1
Facial Palsy
1
Uveitis
1
Eye Infection
1
Renal Transplant
1
Febrile Bone Marrow Aplasia
1
Proctitis Herpes
1
Immunosuppression
1

Zelitrex Case Reports

What Zelitrex safety concerns are being reported by doctors and researchers in the medical literature?

Powered by Google

About Results

This report contains aggregated drug side effects and adverse events for Zelitrex. The data has been pulled from the United States Food and Drug Administration's (US FDA) Adverse Event Reporting System (AERS), a database containing more than 4,000,000 adverse event reports.

DrugCite expands your query using the Unified Medical Language System (UMLS) to include generic drugs and primary active ingredients. While the core of DrugCite's advanced drug filtering algorithm is based on the industry standard UMLS, DrugCite's proprietary filtering system also includes dozens of additional steps to reconcile malformed drug names in the FDA's data.

DrugCite only counts a drug if the submitter of the adverse event indicates that the drug is suspected to have caused the adverse event.

Depending on how the data is aggregated, different counts may occur. When someone submits an adverse event to the FDA, the submitter can attribute multiple adverse events to one or more drugs. For example, an individual taking Paxil could submit the adverse events "anxiety" and "suicidal ideation" for the same individual safety report (ISR). This means when DrugCite aggregates by adverse event, two distinct adverse events are counted in the adverse event graph; once for "anxiety" and again for "suicidal ideation". However, when DrugCite aggregates by individual safety reports irrespective of the details of the adverse events contained within the safety report, the report is only counted once.

Comments

Share your experience with Zelitrex.